Concepedia

Jayashree Sahni

JS

Statistics

Publications

22

Citations

1.4K

H-Index

16

Active since

2003

Affiliations

University of Liverpool(Current)

Royal Liverpool University Hospital

Roche (Switzerland)

Retinal Consultants of Arizona

Southern California Eye Institute

Jayashree Sahni is an author at University of Liverpool specializing in medicine, ophthalmology, and macular degeneration.

ORCID

Publications per year

2003–2024

22

Publications

22

Simultaneous Inhibition of Angiopoietin-2 and Vascular Endothelial Growth Factor-A with Faricimab in Diabetic Macular Edema

Jayashree Sahni, Sunil Patel, Pravin U. Dugel et al. · Ophthalmology · 2019 · 272 citations · Full text

, , +17

Efficacy of Every Four Monthly and Quarterly Dosing of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

Arshad M. Khanani, Sunil Patel, Philip J. Ferrone et al. · JAMA Ophthalmology · 2020 · 180 citations · Full text

, , +17

Safety and Efficacy of Different Doses and Regimens of Faricimab vs Ranibizumab in Neovascular Age-Related Macular Degeneration

Jayashree Sahni, Pravin U. Dugel, Sunil Patel et al. · JAMA Ophthalmology · 2020 · 125 citations · Full text

, , +17

A randomised controlled trial to assess the clinical effectiveness and cost-effectiveness of alternative treatments to Inhibit VEGF in Age-related choroidal Neovascularisation (IVAN)

Usha Chakravarthy, Simon Harding, Chris Rogers et al. · Health Technology Assessment · 2015 · 98 citations · Full text

, , +14

Phase I Trial of Anti–Vascular Endothelial Growth Factor/Anti-angiopoietin 2 Bispecific Antibody RG7716 for Neovascular Age-Related Macular Degeneration

Usha Chakravarthy, Clare Bailey, David M. Brown et al. · Ophthalmology Retina · 2017 · 84 citations · Full text

, , +17

1–5 of 22